CotH3 mediates fungal invasion of host cells during mucormycosis

Journal of Clinical Investigation

Volumn 124, Issue 1, 2014, Pages 237-250

  Gebremariam, Teclegiorgis ^a,b   Liu, Mingfu ^a,b   Luo, Guanpingsheng ^a,b   Bruno, Vincent ^c   Phan, Quynh T ^a,b   Waring, Alan J ^a,d   Edwards Jr , John E ^a,b,d   Filler, Scott G ^a,b,d   Yeaman, Michael R ^a,b,d   Ibrahim, Ashraf S ^a,b,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; COTH2 PROTEIN; COTH3 PROTEIN; GLUCOSE REGULATED PROTEIN 78; INVASIN; UNCLASSIFIED DRUG;

ARTICLE; CHINESE HAMSTER; CHO CELL; DIABETIC KETOACIDOSIS; ENDOCYTOSIS; ENDOTHELIUM CELL; FEMALE; FUNGAL VIRULENCE; GLYCOSYLATION; HETEROLOGOUS EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LICHTHEIMIA CORYMBIFERA; LIMIT OF DETECTION; MOLECULAR DOCKING; MOUSE; MUCOR CIRCINELLOIDES; MUCOR RACEMOSUS; MUCORMYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHIZOMUCOR; RHIZOPUS ORYZAE; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SURVIVAL;

EID: 84892935987     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI71349     Document Type: Article

References (58)

1. Sugar A. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, Pennsylvania, USA: Elsevier; 2005:2979
2. Ibrahim AS, Edwards JJE, Filler SG, Spellberg B. Mucormycosis and entomophthoramycosis (zygomycosis). In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, eds. Essentials of Clinical Mycology. New York, New York, USA: Springer; 2011:265-280
3. Ribes J, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000; 13(2):236-301
4. Ibrahim A. Host cell invasion in mucormycosis: role of iron. Curr Opin Microbiol. 2011;14(4):406-411
5. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48(12):1743-1751
6. Kauffman CA. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis. 2004;39(4):588-590
7. Roden M, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-653
8. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(suppl 1):S16-S22
9. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556-569
10. Neblett Fanfair R, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214-2225
11. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(suppl 1):S23-S34
12. Artis W, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982;31(12):1109-1114
13. Ibrahim A, Edwards JEJ, Filler SG. Zygomycosis. In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York, New York, USA: Oxford University Press; 2003:241-251
14. Ibrahim A, Spellberg B, Avanessian V, Fu Y, Edwards JE Jr. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun. 2005;73(2):778-783
15. Liu M, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010;120(6):1914-1924
16. Wu Y, Li Q, Chen XZ. Detecting protein-protein interactions by Far western blotting. Nat Protoc. 2007;2(12):3278-3284
17. Naclerio G, Baccigalupi L, Zilhao R, De Felice M, Ricca E. Erratum. Bacillus subtilis spore coat assembly requires cotH gene expression. J Bacteriol. 1996;178(21):6407
18. Giorno R, et al. Morphogenesis of the Bacillus anthracis spore. J Bacteriol. 2007;189(3):691-705
19. Isberg RR, Leong JM. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell. 1990;60(5):861-871
20. Morris J, Dorner AJ, Edwards CA, Hendershot LM, Kaufman RJ. Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J Biol Chem. 1997; 272(7):4327-4334
21. Reddy R, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem. 2003;278(23):20915-20924
22. Li J, Lee AS. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med. 2006;6(1):45-54
23. Davidson D, et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res. 2005;65(11):4663-4672
24. Ibrahim A, et al. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. 2010;77(3):587-604
25. Luo G, et al. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis. Antimicrob Agents Chemother. 2013;57(7):3340-3347
26. Phan Q, Fratti RA, Prasadarao NV, Edwards JE Jr, Filler SG. N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J Biol Chem. 2005;280(11):10455-10461
27. Phan Q, et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007;5(3):e64
28. Liu Y, Mittal R, Solis NV, Prasadarao NV, Filler SG. Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog. 2011;7(10):e1002305
29. Nosari A, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85(10):1068-1071
30. Eickhardt S, et al. A non-fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient. APMIS. 2012;121(5):456-459
31. Skiada A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17(12):1859-1867
32. Gomes M, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non- Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24(2):411-445
33. MacDonald S, Corbel MJ. Mortierella wolfii infection in cattle in Britain. Vet Rec. 1981;109(19):419-421
34. Uzal F, Connole MD, OBoyle D, Dobrenov B, Kelly WR. Mortierella wolfii isolated from the liver of a cow in Australia. Vet Rec. 1999;145(9):260-261
35. Hoffmann K, Voigt K. Absidia parricida plays a dominant role in biotrophic fusion parasitism among mucoralean fungi (Zygomycetes): Lentamyces, a new genus for A. parricida and A. zychae. Plant Biol (Stuttg). 2009;11(4):537-554
36. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(suppl 1):S55-S60
37. Walsh T, Chanock SJ. Diagnosis of invasive fungal infections: advances in nonculture systems. Curr Clin Top Infect Dis. 1998;18:101-153
38. Spellberg B, et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012;67(3):715-722
39. Skory C, Ibrahim AS. Native and modified lactate dehydrogenase expression in a fumaric acid producing isolate Rhizopus oryzae 99-880. Curr Genet. 2007;52(1):23-33
40. Orr-Weaver T, Szostak JW, Rothstein RJ. Yeast transformation: a model system for the study of recombination. Proc Natl Acad Sci U S A. 1981; 78(10):6354-6358
41. Pitarch A, Jimenez A, Nombela C, Gil C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics. 2006;5(1):79-96
42. Pitarch A, et al. Two-dimensional gel electrophoresis as analytical tool for identifying Candida albicans immunogenic proteins. Electrophoresis. 1999; 20(4-5):1001-1010
43. Michielse C, et al. Development of a system for integrative and stable transformation of the zygomycete Rhizopus oryzae by Agrobacterium-mediated DNA transfer. Mol Genet Genomics. 2004;271(4):499-510
44. Fu Y, et al. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol. 2002;44(1):61-72
45. Ibrahim A, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007;117(9):2649-2657
46. Jaffe E, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745-2756
47. Ibrahim A, Filler SG, Alcouloumre MS, Kozel TR, Edwards JE Jr, Ghannoum MA. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun. 1995;63(11):4368-4374
48. Ibrahim A, et al. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis. 2008;198(7):1083-1090
49. Mertens J, Skory CD, Ibrahim AS. Plasmids for expression of heterologous proteins in Rhizopus oryzae. Arch Microbiol. 2006;186(1):41-50
50. Skory C. Homologous recombination and doublestrand break repair in the transformation of Rhizopus oryzae. Mol Genet Genomics. 2002;268(3):397-406
51. Antachopoulos C, Meletiadis J, Roilides E, Sein T, Walsh TJ. Rapid susceptibility testing of medically important zygomycetes by XTT assay. J Clin Microbiol. 2006;44(2):553-560
52. Polak E, Ribiere G. Note sur la xonvergence de directions conjugees. Rev Francaise Informat Recherche Operatinelle. 1969;16:35-43
53. Macias A, et al. Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity. J Med Chem. 2011; 54(12):4034-4041
54. Chen R, Li L, Weng Z. ZDOCK: an initial-stage protein- docking algorithm. Proteins. 2003;52(1):80-87
55. Chaudhury S, Berrondo M, Weitzner BD, Muthu P, Bergman H, Gray JJ. Benchmarking and analysis of protein docking performance in Rosetta v3.2. PLoS One. 2011;6(8):e22477
56. Lyskov S, Gray JJ. The RosettaDock server for local protein-protein docking. Nucleic Acids Res. 2008;36(Web Server issue):W233-W238
57. Ibrahim A, Avanessian V, Spellberg B, Edwards JE Jr. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother. 2003;47(10):3343-3344
58. Ibrahim A, et al. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother. 2005;49(2):721-727.